Low molecular weight dextran infusions in systemic sclerosis with Raynaud's phenomenon: a report of nine cases.
作者信息
Lane P
出版信息
Br Med J. 1970 Dec 12;4(5736):657-9. doi: 10.1136/bmj.4.5736.657.
Abstract
Two litres of low molecular weight dextran in normal saline were given intravenously over 48 hours to 10 patients with systemic sclerosis and Raynaud's phenomenon. The finger temperatures of nine were recorded under standardized conditions. One patient had lowered temperatures of the fingers, two had a rise in temperature, and six had no change. There were no side effects of the treatment. None of the 10 patients showed any clinical improvement.
摘要
相似文献
1
Low molecular weight dextran infusions in systemic sclerosis with Raynaud's phenomenon: a report of nine cases.
Br Med J. 1970 Dec 12;4(5736):657-9. doi: 10.1136/bmj.4.5736.657.
2
Low molecular weight dextran in systemic sclerosis and Raynaud's phenomenon.
Acta Derm Venereol. 1982;62(5):440-2.
3
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.前列腺素E1输注治疗进行性系统性硬化症的血管功能不全
Ann Rheum Dis. 1981 Aug;40(4):350-4. doi: 10.1136/ard.40.4.350.
4
Use of biofeedback training in treatment of Raynaud's disease and phenomenon.生物反馈训练在雷诺病及雷诺现象治疗中的应用。
J Rheumatol. 1985 Feb;12(1):90-3.
5
Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.静脉注射伊洛前列素治疗系统性硬化症继发的雷诺现象和缺血性溃疡。
J Rheumatol. 1992 Sep;19(9):1407-14.
6
[Raynaud's phenomena: diagnostic and treatment study].[雷诺现象：诊断与治疗研究]
Rev Prat. 1998 Oct 1;48(15):1659-64.
7
[Raynaud's phenomenon and sclerodermia].[雷诺现象与硬皮病]
Aten Primaria. 2003 Jun 15;32(1):60. doi: 10.1016/s0212-6567(03)78858-1.
8
[Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].[A型肉毒杆菌毒素在治疗系统性硬化症所致雷诺现象中的作用]
Ann Chir Plast Esthet. 2013 Dec;58(6):658-62. doi: 10.1016/j.anplas.2011.11.001. Epub 2011 Dec 26.
9
Treatment of Raynaud phenomenon and ischemic ulcers associated to systemic sclerosis with hyperbaric oxygen.高压氧治疗系统性硬化症相关的雷诺现象和缺血性溃疡。
Reumatol Clin (Engl Ed). 2022 Apr;18(4):246-248. doi: 10.1016/j.reumae.2021.05.004. Epub 2021 Dec 23.
10
Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis.
Br J Dermatol. 1988 Nov;119(5):643-6. doi: 10.1111/j.1365-2133.1988.tb03477.x.
引用本文的文献
1
Prostaglandin E1 therapy for digital ulcers in scleroderma.
Can Med Assoc J. 1982 Jan 1;126(1):42-5.
本文引用的文献
1
LOW-MOLECULAR-WEIGHT DEXTRAN ('RHEOMACRODEX') IN ISCHAEMIC ULCERATION OF THE SKIN.低分子量右旋糖酐（“血容量扩充剂”）用于皮肤缺血性溃疡
Lancet. 1964 Mar 7;1(7332):524-5. doi: 10.1016/s0140-6736(64)92911-3.
2
Rheomacrodex in peripheral ischemia.周围缺血时的流变学改善剂
Lancet. 1963 Jun 1;1(7292):1189-90. doi: 10.1016/s0140-6736(63)92483-8.
3
A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.一种用于临床测量肺一氧化碳弥散能力的标准化屏气技术。
J Clin Invest. 1957 Jan;36(1 Part 1):1-17. doi: 10.1172/JCI103402.
4
Renal failure associated with low-molecular-weight dextran infusion.与输注低分子量右旋糖酐相关的肾衰竭。
Br Med J. 1966 Sep 24;2(5516):737-9. doi: 10.1136/bmj.2.5516.737.
5
The effect of intermittent low molecular dextran infusions upon the digital circulation in systemic sclerosis.间歇性输注低分子右旋糖酐对系统性硬化症患者手指循环的影响。
Br J Dermatol. 1965 Nov;77(11):560-8. doi: 10.1111/j.1365-2133.1965.tb14576.x.
6
Low molecular weight dextran.低分子量右旋糖酐
Med Clin North Am. 1967 Sep;51(5):1285-99. doi: 10.1016/s0025-7125(16)32995-9.
7
Low-molecular-weight dextran in the treatment of peripheral arterial insufficiency.
Lancet. 1965 Nov 20;2(7421):1050-2. doi: 10.1016/s0140-6736(65)90574-x.
Zotero 插件